Prednisolone-induced changes in gene-expression profiles in healthy volunteers

Autor: Wilco W. M. Fleuren, Susanne Bauerschmidt, Ulla Nässander, Marie-Jose van Lierop, Wim H. A. Dokter, Wynand Alkema, Erik J M Toonen
Přispěvatelé: Data Sciences for Life Science & Health
Rok vydání: 2011
Předmět:
Adult
CD4-Positive T-Lymphocytes
Male
Chemical and physical biology [NCMLS 7]
Hydrocortisone
cd4-positive t-lymphocytes/drug effects
Prednisolone
CD14
Anti-Inflammatory Agents
Lipopolysaccharide Receptors
immunosuppressive agents/administration & dosage
insulin-secreting cells/drug effects
lipopolysaccharide receptors/analysis
Pharmacology
Biology
monocytes/drug effects
Monocytes
Biological pathway
Young Adult
In vivo
Insulin-Secreting Cells
Gene expression
adults
gene expression profiling
Genetics
medicine
humans
Adverse effect
metabolisme
Health aging / healthy living Pathogenesis and modulation of inflammation [IGMD 5]
Middle Aged
hydrocortisone/blood
Gene signature
Gene expression profiling
cd4 lymphocyte count
Immunology
Molecular Medicine
prednisolone/administration & dosage
anti-inflammatory agents/administration & dosage
Immunosuppressive Agents
medicine.drug
Zdroj: Pharmacogenomics, 12, 985-98
Pharmacogenomics, 12, 7, pp. 985-98
Pharmacogenomics, 12(7), 985-998. Ashley
ISSN: 1462-2416
Popis: Background: Prednisolone and other glucocorticoids (GCs) are potent anti-inflammatory and immunosuppressive drugs. However, prolonged use at a medium or high dose is hampered by side effects of which the metabolic side effects are most evident. Relatively little is known about their effect on gene-expression in vivo, the effect on cell subpopulations and the relation to the efficacy and side effects of GCs. Aim: To identify and compare prednisolone-induced gene signatures in CD4+ T lymphocytes and CD14+ monocytes derived from healthy volunteers and to link these signatures to underlying biological pathways involved in metabolic adverse effects. Materials & methods: Whole-genome expression profiling was performed on CD4+ T lymphocytes and CD14+ monocytes derived from healthy volunteers treated with prednisolone. Text-mining analyses was used to link genes to pathways involved in metabolic adverse events. Results: Induction of gene-expression was much stronger in CD4+ T lymphocytes than in CD14+ monocytes with respect to fold changes, but the number of truly cell-specific genes where a strong prednisolone effect in one cell type was accompanied by a total lack of prednisolone effect in the other cell type, was relatively low. Subsequently, a large set of genes was identified with a strong link to metabolic processes, for some of which the association with GCs is novel. Conclusion: The identified gene signatures provide new starting points for further study into GC-induced transcriptional regulation in vivo and the mechanisms underlying GC-mediated metabolic side effects. Original submitted 5 January 2011; Revision submitted 24 February 2011
Databáze: OpenAIRE